FDA ANDA Full Approvals Down In FY 2003, Total Applications Increase
Executive Summary
The number of full generic drug approvals dropped slightly in fiscal 2003 to 284, compared to 296 in fiscal 2002
You may also be interested in...
FDA Office Of Generic Drugs Adding Fourth Team To Handle Increased ANDAs
The Center for Drug Evaluation & Research Office of Generic Drugs is adding a fourth team within the Division of Bioequivalence to handle an increase in ANDA submissions, FDA said at a Drug Information Association meeting March 1 in Bethesda, Md
FDA Office Of Generic Drugs Adding Fourth Team To Handle Increased ANDAs
The Center for Drug Evaluation & Research Office of Generic Drugs is adding a fourth team within the Division of Bioequivalence to handle an increase in ANDA submissions, FDA said at a Drug Information Association meeting March 1 in Bethesda, Md
FDA Drug Center Would Lose 44 FTEs Under Fiscal 2005 Budget Request
FDA's fiscal 2005 budget request includes a reduction of 44 full-time equivalent positions in the Center for Drug Evaluation & Research